J. Paillasseur

发表

Clinical COPD phenotypes: a novel approach using principal component and cluster analyses

D. Caillaud, N. Roche, I. Tillie‐Leblond, 2010, European Respiratory Journal.

Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease

D. Caillaud, N. Roche, P. Burgel, 2015, International journal of chronic obstructive pulmonary disease.

Impact of comorbidities on COPD-specific health-related quality of life.

D. Caillaud, N. Roche, I. Court-Fortune, 2013, Respiratory medicine.

Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities

D. Caillaud, N. Roche, I. Court-Fortune, 2019, International journal of chronic obstructive pulmonary disease.

Randomized controlled trials of pharmacological treatments to prevent COPD exacerbations: applicability to real-life patients

N. Roche, P. Burgel, J. Paillasseur, 2019, BMC Pulmonary Medicine.

Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?

D. Caillaud, N. Roche, I. Court-Fortune, 2014, European Respiratory Journal.

Impact of current cough on health-related quality of life in patients with COPD

D. Caillaud, N. Roche, I. Court-Fortune, 2016, International journal of chronic obstructive pulmonary disease.

Prognostic value of six minute walk test in cystic fibrosis adults.

P. Burgel, J. Paillasseur, I. Fajac, 2013, Respiratory medicine.

Association between occupational exposure and the clinical characteristics of COPD

D. Caillaud, N. Roche, I. Court-Fortune, 2012, BMC Public Health.

Two Distinct COPD Phenotypes Are Associated With High Risk Of Mortality

M. Decramer, N. Roche, W. Janssens, 2012, ATS 2012.

COPD_A_295381 1275..1284

D. Caillaud, N. Roche, I. Court-Fortune, 2021 .

Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function.

P. Reix, P. Burgel, J. Paillasseur, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis.

S. Leroy, P. Burgel, J. Paillasseur, 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Identification of Clinical Phenotypes Using Cluster Analyses in COPD Patients with Multiple Comorbidities

Nicolas Roche, N. Roche, P. Burgel, 2014, BioMed research international.

Clinical COPD phenotypes identified by cluster analysis: validation with mortality

D. Caillaud, N. Roche, I. Tillie‐Leblond, 2012, European Respiratory Journal.

Real-world assessment of LCI following lumacaftor-ivacaftor initiation in adolescents and adults with cystic fibrosis.

P. Reix, P. Burgel, J. Paillasseur, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.

D. Caimmi, A. Didier, S. Leroy, 2020, American journal of respiratory and critical care medicine.

Characterization of seawater samples using chemometric methods applied to biomarker fatty acids

J. Paillasseur, J. Marty, A. Saliot, 1988 .

Patient eligibility criteria for a surgical treatment that enhances tissue sealing by use of a medicated sponge: observational study ELITE

J. Paillasseur, P. Sockeel, Y. Gangner, 2013, SpringerPlus.

Rapid Improvement After Starting Elexacaftor-tezacaftor-ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.

P. Burgel, J. Paillasseur, I. Durieu, 2021, American journal of respiratory and critical care medicine.

Cluster and CART analyses identify large subgroups of adults with cystic fibrosis at low risk of 10-year death

S. Stanojevic, P. Burgel, J. Paillasseur, 2019, European Respiratory Journal.

Relationship between gender and survival in a real-life cohort of patients with COPD

D. Caillaud, N. Roche, I. Court-Fortune, 2019, Respiratory Research.

Asthma–COPD overlap syndrome (ACOS) vs ‘pure’ COPD: a distinct phenotype?

D. Caillaud, N. Roche, I. Court-Fortune, 2017, Allergy.

Impact of gender on COPD expression in a real-life cohort

Nicolas Roche, D. Caillaud, N. Roche, 2014, Respiratory Research.

Burden and Characteristics of Severe Chronic Hypoxemia in a Real-World Cohort of Subjects with COPD

D. Caillaud, N. Roche, I. Court-Fortune, 2021, International journal of chronic obstructive pulmonary disease.

A simple algorithm for the identification of clinical COPD phenotypes

M. Decramer, J. Soriano, B. Celli, 2017, European Respiratory Journal.

Two Distinct Chronic Obstructive Pulmonary Disease (COPD) Phenotypes Are Associated with High Risk of Mortality

Thierry Troosters, Marc Decramer, Wim Janssens, 2012, PloS one.

Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD

D. Caillaud, N. Roche, I. Court-Fortune, 2017, International journal of chronic obstructive pulmonary disease.

Phenotypes influencing low physical activity in maintenance dialysis.

J. Paillasseur, C. Lasseur, D. Fouque, 2015, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Real-life use of long-acting antimuscarinic agents following their approval for COPD treatment

D. Caillaud, N. Roche, I. Court-Fortune, 2015, European Respiratory Journal.

Asthma-COPD overlap syndrome (ACOS) versus "pure" COPD: A distinct phenotype?

D. Caillaud, N. Roche, I. Court-Fortune, 2016 .

Tiotropium might improve survival in subjects with COPD at high risk of mortality

Yufeng Liu, M. Decramer, N. Roche, 2014, Respiratory Research.

Impact of comorbidities on COPD-specific health-related quality of life.

D. Caillaud, N. Roche, I. Court-Fortune, 2013, Respiratory medicine.